Name: Opportunity to buy Scholar Rock ‘in the beginnings’ of new drug launch: Nierengarten
Uploaded: 2026-11-12T16:50:06Z
Duration: 6 min 23 s
Description: David Nierengarten, senior analyst at Wedbush, joins BNN Bloomberg to share his Hot Picks in biotech.

The Open

Opportunity to buy Scholar Rock ‘in the beginnings’ of new drug launch: Nierengarten

David Nierengarten, senior analyst at Wedbush, joins BNN Bloomberg to share his Hot Picks in biotech.

November 12, 2026 at 11:17a.m. EST